A retrospective drug utilization study of antidepressants in the psychiatricunit of a tertiary care hospital

Journal of Clinical and Diagnostic Research

Volumn 5, Issue 5, 2011, Pages 1069-1075

  Lahon, Kingshuk ^a   Shetty, Harsha M ^a   Paramel, Amith ^a,b   Sharma, Gyaneswar ^a  

^a MAHATMA GANDHI MEDICAL COLLEGE AND RESEARCH INSTITUTE   (India)

^b Therapeutic Community and Unity House   (United Kingdom)

Author keywords

Antidepressants; ATC; DDD; Drug utilization; PDD

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DULOXETINE; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; MIRTAZAPINE; SERTRALINE; TRAZODONE;

ADJUSTMENT DISORDER; ADOLESCENT; ADULT; AGE DISTRIBUTION; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CHILD; CONTROLLED STUDY; DEPRESSION; DISSOCIATIVE DISORDER; DRUG UTILIZATION; FEMALE; HUMAN; HYPERKINESIA; INDIA; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CENTER; MIXED ANXIETY AND DEPRESSION; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PANIC; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; PSYCHOSIS; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SCHOOL CHILD; SEX DIFFERENCE; SOCIAL PHOBIA; TERTIARY HEALTH CARE; WORLD HEALTH ORGANIZATION;

EID: 80054772590     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. World Health Organisation Introduction to drug utilisation research. Oslo: World Health Organisation, 2003.
2. Lunde PKM, Levy M. Drug utilization - geographical differences and clinical implications. Introductory remarks. In: Duchene-Marullaz, P, ED. Advances in pharmacology and therapeutics. Oxford, Pergamon Press 1978;6:79-82.
3. Gross F. Drug utilization therapy and practice. The present situation in the Federal Republic of Germany. Eur J Clin Pharmacol 1981;19: 387-94.
4. Cochrane AL. Effectiveness and efficiency - Random reflections on health services. London, The Nuffield Provincial Hospitals Trust, 1982.
5. Stolley PD, Lasagna L. Prescribing patterns of physicians. Journal of chronic diseases 1969; 22:395-405.
6. Westerholm B. Therapeutic auditing at the national and international levels. Br J Clin Pharmacol, 1986;22:55S-59S.
7. Pullar T, Kumar S, Tindall H, Freely M. Time to stop counting the tablets? Clin Pharmacol Ther 1989;46:163-8.
8. Tognoni G, Laporte JR. From Clinical trials to Drug utilization studies. In: Dukes, M.N.G., ED. Drug utilization studies - Methods and uses. Denmark: WHO Regional publications, European Series 1993;45: 28-30.
9. Organisation for economic cooperation and development. OECD Policy brief - Mental health in OECD countries. Paris: OECD, 2008 Nov . Accessed February 7, 2011.
10. World Health Organisation. The ICD-10 Classification of Behavioural and Mental Disorders. Diagnostic criteria for research. Geneva: World Health Organisation, 1993. . Accessed December 6, 2010.
11. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J. Patterns of psychotropic drug prescription for US patients with the diagnoses of bipolar disorders. Psychiatr Serv 2007 Jan;58(1):85-91.
12. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for defined daily doses. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1991.
13. Morabia A, Fabre J, Dunand JP. The influence of patient and physician gender on the prescription of psychotropic drugs. J Clin Epidemiol 1992;45:111-6.
14. The ESEMeD/MHEDEA 2000 investigators. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004;109 (Suppl. 420):55-64.
15. Uchida N, Chong MY, Tan CH, Nagai H, Tanaka M, Lee MS et al. International study on antidepressant prescription pattern at 20 teaching hospitals and major psychiatric institutions in East Asia: Analysis of 1898 cases from China, Japan, Korea, Singapore and Taiwan. Psychiatry and Clinical Neurosciences 2007;61:522-8.
16. Olfson M, Marcus SC, Pincus HA, Zito JM, Thompson JW, Zarin DA. Antidepressant prescribing practices of outpatient psychiatrists. Arch Gen Psychiatry 1998; 55:310-16.
17. Hamels ME, Koren G, Einarson TR. Increased use of antidepressants in Canada: 1981-2000. Ann Pharmacother 2002;36:1375-9.
18. Hansen DG, Sondergaard J, Vach W, Gram LF, Rosholm JU, Kragstrup J. Antidepressant drug use in general practice: Inter-practice variation and the association with practice characteristics. Eur J Clin Pharmacol 2003;59:143-9.
19. Pirraglia PA, Stafford RS, Singer DE. Trends in the Prescribing of Selective Serotonin Reuptake Inhibitors and other newer antidepressant agents in adult primary care. Primary care companion. J Clin Psychiatry 2003;5:153-7.
20. National Collaborating Centre for Mental Health. National clinical practice guideline No 23 - Depression: Management of depression in primary and secondary care. Leicester: British Psychological society and Royal College of Psychiatrists, 2004.
21. Fochtmann LJ, Gelenberg AJ. Guideline watch: Practice guidelines for the treatment of patients with major depressive disorders, 2nd edition. Focus 2005;3:34-42.
22. Buxton ILO. Principles of Prescription Order Writing and Patient Compliance. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman's The Pharmacological basis of Therapeutics. 11th edition. USA: McGraw Hill, 2006: 694.
23. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clin Interv Aging 2008 June; 3(2): 383-9.
24. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2002.
25. WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2002.
26. De las CC, Sanz E, De La F J. Variations in antidepressant prescribing practices: clinical need or marketing influences? Pharmacoepidemiol Drug Saf 2002; 11: 515-22.
27. Stafford RS, MacDonald EA, Finkelstein SN. National Patterns of Medication Treatment for Depression, 1987 to 2001. Primary Care Companion J Clin Psychiatry 2001; 3(6): 232-5.
28. WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services. Introduction to Drug Utilization Research. Oslo: World Health Organisation, 2003.
29. Smalbrugge M, Jongenelis LK, Pot AM, Beekman ATF, Eefsting JA. Pain among nursing home patients in the Netherlands: prevalence, course, clinical correlates, recognition and analgesic treatment - an observational cohort study. BMC Geriatrics 2007;7:3.